The lungs are the second most common site of metastasis for colorectal cancer (CRC) after
the liver. Rectal cancer is associated with a higher incidence of lung metastases compared …

Colorectal cancer (CRC) is a frequently occurring disease, yet diagnosed at a local stage in
only 40% of cases. Lung metastases (LM) appear in 5–15% of patients and, left untreated …

Introduction Stereotactic ablative radiotherapy (SABR) has been shown to increase survival
in oligometastatic disease, but local control of colorectal metastases remains poor. We …

Background We evaluated a series of oligometastatic colorectal cancer (CRC) patients
treated with stereotactic ablative body radiotherapy (SABR) delivered in all active lung …

OBJECTIVES: Although wedge resection is the most common surgical procedure for
pulmonary metastases from colorectal cancer, there are few reports about segmentectomy …

For patients with extrapulmonary primary malignancies, the lung is the most frequent site of
metastatic spread. 1 Pulmonary metastatic disease is experienced commonly in colorectal …

Pulmonary metastasectomy is an established treatment that can provide improved long-term
survival for patients with metastatic tumor (s) in the lung. In this mini-review, we discuss the …

It is not clear as to which is the best treatment among surgery and stereotactic radiotherapy
(SBRT) for lung oligometastases. A systematic review of literature with a priori selection …

Background Pulmonary metastasectomy is considered a potentially curative treatment for
selected patients with metastatic colorectal cancer (CRC). Several prognostic factors have …

Colorectal cancer (CRC) is one of the leading causes of cancer-related deaths worldwide. It
is estimated that 50% of all patients with CRC develop metastases, most commonly in the …